ThursdayNov 05, 2026 3:48 pm

QualityStocksNewsBreaks – Silynxcom Ltd. (NYSE American: SYNX) Develops AI-Powered Wearable Drone Detection System for Growing Defense Market

Silynxcom (NYSE American: SYNX) is expanding into the counter-drone defense market with the development of an AI-powered wearable detection and early-warning system designed to protect individual soldiers from unmanned aircraft threats. The prototype-stage technology uses acoustic signatures and artificial intelligence to passively detect approaching drones without relying on radio-frequency emissions, potentially allowing it to identify fiber-optic-guided drones that conventional RF-based detection systems may miss. The company is also developing mesh-networking capabilities that would enable detection alerts to be shared among connected soldiers, extending early-warning capabilities across military units without depending on existing radio networks or fixed infrastructure. Building on its…

Continue Reading

ThursdayNov 05, 2026 3:23 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Advances Telerobotic Surgery with 195 Remote Procedures Across Global Markets

SS Innovations International (NASDAQ: SSII) is strengthening its position in the emerging telerobotic surgery market as advances in surgical robotics and communications technology create new opportunities for remote medical procedures. The company’s SSi Mantra surgical robotic system has supported 195 robotic telesurgeries as of September 28, 2026, including cardiac procedures and operations performed across significant geographic distances. Alongside its telesurgery developments, SS Innovations reported a 45% increase in its installed base to 244 systems across 12 countries, with cumulative surgical procedures reaching 14,503 and approximately 1,500 physicians trained on the platform. Recent international expansion includes new robotic cardiac surgery programs…

Continue Reading

ThursdayNov 05, 2026 2:33 pm

QualityStocksNewsBreaks – Earth Science Tech Inc. (ETST) Builds Long-Term Value Through Strategic Integration

Earth Science Tech (OTCQB: ETST), a diversified holding company operating across healthcare, pharmacy, technology, telemedicine, real estate, and consumer products, is leveraging synergies among its subsidiaries to support long-term growth and generate dependable revenue. Its real estate and asset management subsidiary, Avenvi LLC, contributes to this strategy through its diversified real estate portfolio, property development expertise, and financing solutions for property purchasers. In addition to managing investments and overseeing ETST’s share repurchase program, Avenvi provides essential physical infrastructure for the company’s expanding pharmacy operations, including housing the standalone Mister Meds compounding pharmacy in Texas. Through its real estate capabilities, disciplined…

Continue Reading

ThursdayNov 05, 2026 2:03 pm

QualityStocksNewsBreaks – Why Adaptogenics Health Corp. (CSE: ADPT) Is ‘One to Watch’

Disseminated on behalf of Adaptogenics Health Corp. and may include paid advertising. Adaptogenics (CSE: ADPT) was featured in a recent article that discussed its efforts to build a healthcare company focused on opportunities across the rapidly evolving peptide sector, combining proprietary therapeutic development, pharmaceutical-quality supply infrastructure and innovative drug delivery technologies. “As demand for solutions addressing metabolic health, muscle preservation, recovery and healthy ageing continues to grow, Adaptogenics is positioning itself to address significant healthcare challenges while pursuing opportunities in the expanding market for high-quality peptide development and supply,” the article reads. “The company’s strategy combines experienced pharmaceutical leadership, scientific…

Continue Reading

FridayOct 30, 2026 3:54 pm

QualityStocksNewsBreaks – Market Street Capital Inc. Brings Capital Markets Expertise to Healthcare Financing

Market Street was featured in an article that highlights its capital markets and financial advisory services for middle-market healthcare companies navigating reimbursement uncertainty, industry consolidation, heightened compliance scrutiny and increasingly selective investors. With potential Medicare laboratory reimbursement cuts beginning in 2027, lenders and private equity sponsors are placing greater emphasis on revenue diversification, payer relationships, regulatory compliance and sustainable cash flow when evaluating financing and acquisition opportunities. Market Street supports healthcare businesses through debt financing, private equity raises, mergers and acquisitions, valuation and strategic advisory services, connecting clients with banks, private credit funds, institutional investors and other potential capital sources.…

Continue Reading

FridayOct 30, 2026 3:34 pm

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Strengthens Portfolio with Emergent Metals Acquisition

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) was featured in a recent article that discussed expansion of its Nevada gold and silver portfolio through a definitive agreement to acquire Emergent Metals Corp., which would consolidate its ownership of the West Santa Fe property, eliminate royalty obligations on West Santa Fe and 27 adjacent York claims, and add the strategically located New York Canyon project. The transaction would increase Lahontan’s Walker Lane land package to more than 93 square kilometers as gold prices remain historically elevated,…

Continue Reading

FridayOct 30, 2026 2:40 pm

QualityStocksNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRAP) Builds Broader Public Safety Platform Around Integrated Solutions

Wrap Technologies (NASDAQ: WRAP) is expanding its public safety technology strategy by connecting remote restraint, scenario-based training, evidence management and emerging threat-detection systems into a more integrated offering. Its portfolio includes the BolaWrap 150 restraint device, WRAP Reality virtual reality training simulator and WrapShield platform, which initially focuses on detecting and responding to unmanned aircraft threats. The company recently appointed veteran law enforcement instructor John “Chappy” Chapman as vice president of Training and Missions to oversee a planned four-level instructor credentialing framework, digital learning expansion and broader adoption of its Non-Lethal Response doctrine. WRAP is also developing Wraptor MX, a…

Continue Reading

FridayOct 30, 2026 1:31 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Expands NAMs Strategy to Advance BiTAC(R) Therapies

VERAXA Biotech (NASDAQ: VRXA) is expanding its use of human-relevant preclinical testing methods across its antibody-based cancer drug development programs, aiming to improve the clinical relevance of research findings while reducing animal testing. The company is implementing New Approach Methodologies (“NAMs”), including three-dimensional tumor spheroid models and patient-derived tumor models, in support of its BiTAC(R) T-cell engagers, antibody-drug conjugates and bispecific antibody-drug conjugates. VERAXA reported that its lead BiTAC T-cell engager demonstrated selective, potent T-cell-mediated tumor-cell killing across 10 patient-derived non-small cell lung cancer models, while relevant controls showed minimal activity. The ex vivo study required approximately 10 mice, compared…

Continue Reading

FridayOct 30, 2026 12:54 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Taps Thermo Fisher’s Clinical Research Business for Lucid-MS Trial

Quantum BioPharma (NASDAQ: QNTM) has signed a Study Start-Up Agreement with Thermo Fisher Scientific’s clinical research business to support the Phase 2 clinical trial of Lucid-MS, its investigational drug candidate for progressive multiple sclerosis (“MS”). Following U.S. Food and Drug Administration clearance of its Investigational New Drug application in August 2026, the agreement moves the program toward clinical implementation with a contract research organization experienced in central nervous system and MS studies. Unlike many existing MS treatments that primarily target the immune system, Lucid-MS is designed to protect myelin, the protective coating around nerve fibers, by inhibiting PAD2, an enzyme…

Continue Reading

ThursdayOct 29, 2026 3:51 pm

QualityStocksNewsBreaks – American Fusion Inc. (AMFN) Positions Texatron(TM) Development Around Race to Power AI

American Fusion (OTC: AMFN) is advancing testing of its Texatron(TM) Fusion Engine(TM) as it explores opportunities to supply electricity to AI data centers and other power-intensive customers. In a recent AGORACOM interview, Executive Chairman Brent Nelson discussed the company’s 500-kW and 5-MW pre-production systems, plans for larger 10-MW and 20-MW configurations, and a development roadmap covering 12 authorized model classes ranging from approximately 500 kW to 1 GW. The company is targeting documented test results demonstrating energy generation and capture, with a goal of reaching unity or beyond unity by the end of 2026. American Fusion is also exploring a…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered